The photovoltaic power plant ensures the production of an annual amount of electricity that will cover 26.4% of the operating needs of the industrial platform in the city of Iași, based on the consumption recorded in 2021.
“The reduction of the carbon footprint, in the strive of the EU to achieve the climate neutrality by 2050, is a strategic concern for Antibiotice. We have built an energy efficiency strategy on our platform to ensure a certain degree of energy autonomy in industrial processes and this investment is an important step towards this goal. From the total annual energy consumed, we will ensure, through this photovoltaic park, more than a quarter of the energy from renewable sources and this aspect will significantly contribute to the decarbonization process”, stated Ioan Nani, the General Director of Antibiotice Iași.
The new electricity production capacity from renewable sources (solar energy) is located on the ground, on the company’s platform and it stretches over a built surface of 31,428 m2 , with 4,680 photovoltaic panels installed.
In 2024, an assembly of photovoltaic panels will also be implemented on the company’s buildings with a power of 1.2 MW, so that the green energy production will ensure an energy autonomy up to approximately 35% of the needs of the industrial platform.
Currently, the company’s sustainability strategy focuses on measures to reduce carbon emissions through energy efficiency, by renewing the fleet with electric cars and also by increasing the percentage of electricity purchased from renewable sources.
The photovoltaic plant project was implemented by Parapet, a construction company operating in the renewable sector, providing design, mechanical, electrical and management infrastructure solutions.
(English version by Catalina Apostoiu)